Maze Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 8 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2024 | Sep2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross Margin | 91.04% | |||||||
| EBT Margin | 85.32% | -1,001.24% | -121.04% | |||||
| EBIT Margin | 84.58% | -969.16% | -132.77% | |||||
| EBITDA Margin | 84.58% | -969.16% | -132.77% | |||||
| Operating Margin | 84.58% | -969.16% | -132.77% | |||||
| Net Margin | 84.28% | -989.24% | -121.04% | |||||
| FCF Margin | 87.81% | -932.32% | -196.03% | |||||
| Efficiency | ||||||||
| Assets AverageAssets Avg. | 286.69M | 318.18M | 362.79M | 409.59M | 408.42M | 475.67M | ||
| Invested CapitalInvested Cap. | 380.53M | 492.08M | ||||||
| Asset Utilization RatioAsset Util. | 0.58 | 0.01 | 0.05 | 0.04 | ||||
| Leverage & Solvency | ||||||||
| Interest Coverage RatioInterest Cover | -30.66 | -51.60 | ||||||
| Debt Ratio | 0.09 | 0.07 | ||||||
| Times Interest Earned | -30.66 | -51.60 | ||||||
| Valuation | ||||||||
| Price to EarningsP/E | -9.61 | -15.98 | -41.43 | -290.63 | -61.33 | -37.03 | ||
| Price to SalesP/S | 74.23 | |||||||
| Price to BookP/B | 1.08 | 2.05 | 3.29 | 5.76 | 4.34 | 3.66 | ||
| Enterprise Value | 20.83M | 273.51M | 862.70M | 1,702.05M | 1,132.29M | 1,245.17M | ||
| EV to EBIT | -0.59 | -7.50 | -26.17 | -44.72 | -42.64 | -25.92 | ||
| EV to EBITDA | -0.59 | -7.50 | -26.17 | -44.72 | -42.64 | -25.92 | ||
| Market Capitalization | 315.20M | 538.05M | 1,246.63M | 2,043.97M | 1,484.67M | 1,656.26M | ||
| Price to FCFP/FCF | -10.57 | -17.67 | -50.45 | -73.62 | -37.87 | -109.25 | ||
| EV to FCF | -0.70 | -8.98 | -34.91 | -61.30 | -28.88 | -82.14 | ||
| EV to CFO | -0.71 | -9.10 | -35.01 | -61.38 | -28.95 | -82.72 | ||
| Return Ratios | ||||||||
| Return on Sales [ROS]ROS | 84.58% | -969.16% | 29.97% | -5,033.20% | -132.77% | -728.06% | ||
| Return on Capital Employed [ROCE]ROCE | 18.73% | -42.19% | -39.50% | -36.92% | -34.62% | -32.16% | ||
| Return on Assets [ROA]ROA | 14.62% | -41.11% | -37.54% | -25.29% | -23.26% | -22.30% |